Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing ...

The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the ...

SAN DIEGO — GLP-1 agonists may be protective against hip fracture when administered for the treatment of type 2 diabetes, according to results presented here. Testosterone therapy plus lifestyle ...

One system consisted of a Stockert SIII roller pump (Sorin Group USA, Arvada, CO) with a Tygon S-95 tubing raceway (Saint-Gobain Performance Plastics, Portage, WI), a Medtronic 0800 or 1500 ...

He is a member of a number of advisory boards for companies developing novel diagnostic and therapeutic options for diabetes therapy, including Roche Diagnostics, Sanofi, Abbott, and Medtronic.

After hours: March 12 at 6:56:03 PM EDT Loading Chart for MDT ...

The analysts made the prediction after speaking with Dexcom. Management does not expect the FDA’s review of Dexcom’s 15-day sensor to be affected, the analysts added. Dexcom received FDA observations ...

Pre-Market: 4:24:47 a.m. EDT Loading Chart for TNDM ...